At the forefront of the New Health Economy
PwC’s Health Research Institute (HRI) supports executive decision makers by providing new intelligence and analysis on trends affecting health industries.
PwC’s Health Research Institute examines the top health industry issues of 2021 including virtual health, clinical trial disruption, M&A, resilient supply chains and interoperability.
COVID-19 vaccines are being developed at a breakneck pace, but a broken supply chain could derail that momentum, stunting the economic recovery and likely increasing the number of lives lost. The millions of vaccines produced on the most advanced platforms will likely mean little if consumers who need them most can’t get them. There are steps manufacturers and distributors can take to help ensure the medical supply chain is up to the task of quickly turning these vaccines into vaccinations.
PwC’s Health Research Institute (HRI) has identified three factors that could influence on-time delivery and vaccination for COVID-19.
As a healthcare executive, you face a dynamic industry. Powerful drivers—including surging consumerism, immense technological innovation and ever-evolving regulations—are reshaping the healthcare value chain. PwC’s Health Research Institute (HRI) is here to help you navigate this change through primary research and collaborative exchange. A group of seasoned professionals, HRI is dedicated to delivering new intelligence, perspectives and analysis on trends affecting all corners of the New Health Economy.
The latest regulatory and legislative updates and analysis